Enterprise Value
683.1M
Cash
508.7M
Avg Qtr Burn
-34.48M
Short % of Float
29.25%
Insider Ownership
9.89%
Institutional Own.
-
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
VERVE-102 (ANGPTL3) Details Hypercholesterolemia | Phase 1b Initiation | |
VERVE-102 (PCSK9) Details Hypercholesterolemia | Phase 1b Initiation | |
VERVE-101 (PCSK9) Details Hypercholesterolemia | Phase 1 Data readout |